Elevance Health, Inc. (ELV)
(Delayed Data from NYSE)
$503.89 USD
+3.77 (0.75%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $504.14 +0.25 (0.05%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth A Momentum B VGM
Cash flow Statements
Fiscal Year End for Elevance Health, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 5,991.00 | 6,019.00 | 6,095.00 | 4,572.00 | 4,807.00 |
Depreciation/Amortization & Depletion | 1,745.00 | 1,675.00 | 1,302.00 | 1,154.00 | 1,133.00 |
Net Change from Assets/Liabilities | -535.00 | 253.00 | 1,193.00 | 5,203.00 | -192.00 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 860.00 | 452.00 | -226.00 | -241.00 | 313.00 |
Net Cash From Operating Activities | 8,061.00 | 8,399.00 | 8,364.00 | 10,688.00 | 6,061.00 |
Property & Equipment | -1,296.00 | -1,152.00 | -1,087.00 | -1,021.00 | -1,077.00 |
Acquisition/ Disposition of Subsidiaries | -1,552.00 | -649.00 | -3,476.00 | -1,976.00 | 0.00 |
Investments | -2,622.00 | -2,639.00 | -5,012.00 | -4,282.00 | -1,665.00 |
Other Investing Activities | -102.00 | -120.00 | -63.00 | -45.00 | -50.00 |
Net Cash from Investing Activities | -5,572.00 | -4,560.00 | -9,638.00 | -7,324.00 | -2,792.00 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -2,524.00 | -2,134.00 | -1,697.00 | -2,524.00 | -1,514.00 |
Issuance (Repayment) of Debt | 665.00 | 872.00 | 1,394.00 | 402.00 | 1,053.00 |
Increase (Decrease) Short-Term Debt | -3.00 | 1,225.00 | 2,281.00 | 149.00 | -868.00 |
Payment of Dividends & Other Distributions | -1,395.00 | -1,229.00 | -1,104.00 | -954.00 | -818.00 |
Other Financing Activities | -92.00 | -52.00 | -451.00 | 360.00 | -119.00 |
Net Cash from Financing Activities | -3,349.00 | -1,318.00 | 423.00 | -2,567.00 | -2,266.00 |
Effect of Exchange Rate Changes | -1.00 | -14.00 | -10.00 | 7.00 | 0.00 |
Net Change In Cash & Equivalents | -861.00 | 2,507.00 | -861.00 | 804.00 | 1,003.00 |
Cash at Beginning of Period | 7,387.00 | 4,880.00 | 5,741.00 | 4,937.00 | 3,934.00 |
Cash at End of Period | 6,526.00 | 7,387.00 | 4,880.00 | 5,741.00 | 4,937.00 |
Diluted Net EPS | 25.22 | 24.81 | 24.73 | 17.98 | 18.47 |
Fiscal Year End for Elevance Health, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 4,550.00 | 2,249.00 | 5,991.00 | 5,160.00 | 3,860.00 |
Depreciation/Amortization & Depletion | 666.00 | 331.00 | 1,745.00 | 1,321.00 | 895.00 |
Net Change from Assets/Liabilities | -2,943.00 | -988.00 | -535.00 | 3,821.00 | 3,611.00 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 152.00 | 386.00 | 860.00 | 730.00 | 53.00 |
Net Cash From Operating Activities | 2,425.00 | 1,978.00 | 8,061.00 | 11,032.00 | 8,419.00 |
Property & Equipment | -602.00 | -279.00 | -1,296.00 | -970.00 | -651.00 |
Acquisition/ Disposition of Subsidiaries | -725.00 | -1,120.00 | -1,552.00 | 12,961.00 | -1,651.00 |
Investments | -1,736.00 | -882.00 | -2,622.00 | -16,452.00 | -1,508.00 |
Other Investing Activities | -65.00 | -29.00 | -102.00 | -82.00 | -46.00 |
Net Cash from Investing Activities | -3,128.00 | -2,310.00 | -5,572.00 | -4,543.00 | -3,856.00 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -872.00 | -469.00 | -2,524.00 | -1,636.00 | -1,187.00 |
Issuance (Repayment) of Debt | 2,580.00 | 0.00 | 665.00 | 666.00 | 756.00 |
Increase (Decrease) Short-Term Debt | -159.00 | 976.00 | -3.00 | -842.00 | -735.00 |
Payment of Dividends & Other Distributions | -757.00 | -379.00 | -1,395.00 | -1,049.00 | -701.00 |
Other Financing Activities | -92.00 | -96.00 | -92.00 | -94.00 | -94.00 |
Net Cash from Financing Activities | 700.00 | 32.00 | -3,349.00 | -2,955.00 | -1,961.00 |
Effect of Exchange Rate Changes | -5.00 | 0.00 | -1.00 | -2.00 | 2.00 |
Net Change In Cash & Equivalents | -8.00 | -300.00 | -861.00 | 3,532.00 | 2,604.00 |
Cash at Beginning of Period | 6,505.00 | 6,526.00 | 7,387.00 | 7,387.00 | 7,387.00 |
Cash at End of Period | 6,497.00 | 6,226.00 | 6,526.00 | 10,919.00 | 9,991.00 |
Diluted Net EPS | 9.85 | 9.59 | 3.68 | 5.45 | 7.79 |